Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study (Q33913959)
scientific article
Language:
(P31) (Q13442814)
(P304) 3025-3030
(P407) (Q1860)
(P433) 16
(P478) 18
(P577) Tuesday, August 1, 2000
(P1433) (Q400292)
(P1476) "Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study" (language: en)
(P2093) C Haioun
E Lepage
C Gisselbrecht
G Salles
B Coiffier
P Brice
A Bosly
P Morel
C Nouvel
H Tilly
P Lederlin
C Sebban
J Brière
P Gaulard
F Reyes
other details
description scientific article

External Links